Suppr超能文献

巴西一家参考中心对重型地中海贫血和糖尿病患者的特征描述。

Characterization of thalassemia major and diabetes mellitus patients at a reference center in Brazil.

作者信息

Olivatto Gabriela Marsola, Teixeira Carla Regina de Souza, Sisdelli Marcela Ganzella, Zanetti Maria Lúcia, Silveira Renata Cristina de Campos Pereira, Gonçalves Claudio Vinicius

机构信息

Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo (EERP-USP), Ribeirão Preto, SP, Brazil.

Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo (EERP-USP), Ribeirão Preto, SP, Brazil.

出版信息

Hematol Transfus Cell Ther. 2019 Apr-Jun;41(2):139-144. doi: 10.1016/j.htct.2018.08.005. Epub 2018 Dec 31.

Abstract

OBJECTIVE

This is a quantitative transversal study that aimed to analyze the sociodemographic and clinical characteristics of thalassemia major patients with and without diabetes mellitus.

METHOD

The cohort consisted of 31 thalassemia major patients from a reference center of treatment in Brazil in 2016. The data were obtained from an interview using a questionnaire containing demographic and clinical variables. The results show that 16.1% of the participants with thalassemia major had diabetes mellitus. The participants' ages ranged from 20 to 48 years, with an average of 35 years, mostly students and starting in the formal job market. The most commonly used treatment was the oral desferasirox and the transfusion treatment interval was 15-22 days.

RESULTS

Patients with thalassemia major and diabetes mellitus presented altered values of fasting glycemia, serum alanine transaminase, magnetic resonance imaging and bone densitometry.

CONCLUSION

It was concluded that knowledge of the characteristics of this population contributes in the proposal of effective educational strategies in light of the complexity of care and the progression of the disease.

摘要

目的

这是一项定量横断面研究,旨在分析患有和未患有糖尿病的重型地中海贫血患者的社会人口学和临床特征。

方法

该队列由2016年来自巴西一个治疗参考中心的31例重型地中海贫血患者组成。数据通过使用包含人口统计学和临床变量的问卷进行访谈获得。结果显示,16.1%的重型地中海贫血参与者患有糖尿病。参与者年龄在20至48岁之间,平均35岁,大多数是学生且刚开始进入正规就业市场。最常用的治疗方法是口服地拉罗司,输血治疗间隔为15 - 22天。

结果

患有重型地中海贫血和糖尿病的患者空腹血糖、血清丙氨酸转氨酶、磁共振成像和骨密度测定值出现改变。

结论

得出的结论是,鉴于护理的复杂性和疾病的进展,了解该人群的特征有助于提出有效的教育策略。

相似文献

5
9
Diabetes mellitus in patients with thalassemia major.重型地中海贫血患者的糖尿病。
Pediatr Blood Cancer. 2014 Jan;61(1):20-4. doi: 10.1002/pbc.24754. Epub 2013 Sep 20.

本文引用的文献

4
The experience of thalassemic adults with their treatment.
Rev Lat Am Enfermagem. 2011 Jul-Aug;19(4):968-76. doi: 10.1590/s0104-11692011000400016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验